…to protect more than $2 billion in annual sales, according to a lawsuit filed by a lawyer who has won multimillion-dollar verdicts against other drugmakers.
Officials at Glaxo, Europe’s biggest drugmaker, knew research showed Avandia users faced an increased risk of heart attack and failed to warn them, attorney Mark Lanier said in the suit filed Sept. 7 in federal court in New York.
Lanier, who won a $253 million verdict against Merck & Co. over its withdrawn Vioxx painkiller, sued Glaxo on behalf of Avandia user Frank Curley. Curley suffered a heart attack in 2004.
“Avandia poses significant safety risks due to defects in its design and inadequate labeling,” Lanier said in the suit, which is seeking more than $100 million in damages.
Full story here at Bloomberg.
And thanks to PharmaGossip as well.
I wonder if JP Garnier will be allowed to see out his time to retirement?
You really wouldn’t bet against the institutional shareholders thinking that JP really ought to be forced out as soon as possible – he just hasn’t delivered for the shareholders – as Napoleon might have said – “give me lucky CEOs”
Sorry JP – that’s not you.